A Study to Evaluate the Safety, Tolerability, Pharmacokinetics of TB001 in Healthy Subjects

NCT05308940 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Healthy

Interventions

DRUG: TB001
DRUG: TB001
DRUG: Placebo
DRUG: Placebo

Sponsor

Shenzhen Turier Biotech Co., Ltd